Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 6
2017 4
2018 10
2019 19
2020 12
2021 19
2022 23
2023 26
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mingde wang (25 results)?
Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.
Fan ZQ, Serenari M, Lv X, Schwartz M, Qiu W, Pawlik TM, Chen Z, Zhou YH, Wang XM, Chen TH, Li J, Zhang CW, Wang H, Zhang YM, Gu WM, Liang YJ, Diao YK, Yao LQ, Li C, Cescon M, Wang MD, Sun XD, Lau WY, Shen F, Yang T, Lv G. Fan ZQ, et al. Br J Surg. 2024 Mar 2;111(3):znae047. doi: 10.1093/bjs/znae047. Br J Surg. 2024. PMID: 38456676 No abstract available.
Grading severity of microscopic vascular invasion was independently associated with recurrence and survival following hepatectomy for solitary hepatocellular carcinoma.
Yao LQ, Li C, Diao YK, Liang L, Jia HD, Tang SC, Zeng YY, Wu H, Wang MD, Gu LH, Pawlik TM, Lau WY, Zhang CW, Shen F, Wang K, Yang T. Yao LQ, et al. Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):16-28. doi: 10.21037/hbsn-22-411. Epub 2023 Mar 6. Hepatobiliary Surg Nutr. 2024. PMID: 38322222 Free PMC article.
Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma a multicenter propensity matching analysis.
Xu X, Wang MD, Xu JH, Fan ZQ, Diao YK, Chen Z, Jia HD, Liu FB, Zeng YY, Wang XM, Wu H, Qiu W, Li C, Pawlik TM, Lau WY, Shen F, Lv GY, Yang T. Xu X, et al. Front Immunol. 2024 Jan 8;14:1322233. doi: 10.3389/fimmu.2023.1322233. eCollection 2023. Front Immunol. 2024. PMID: 38268916 Free PMC article.
Development and validation of prealbumin-bilirubin score (preALBI score) for predicting long-term survival after hepatectomy for hepatocellular carcinoma: A multicenter analysis versus ALBI score.
Li C, Wang MD, Sun XD, Diao YK, Yao LQ, Wang H, Liang YJ, Zhou YH, Gu WM, Chen TH, Chen Z, Gu LH, Shen F, Lv GY, Yang T, Huang DS. Li C, et al. Am J Surg. 2024 Jan 10:S0002-9610(24)00010-2. doi: 10.1016/j.amjsurg.2024.01.009. Online ahead of print. Am J Surg. 2024. PMID: 38238192
Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score.
Sun LY, Wang NY, Diao YK, Yan CL, Fan ZP, Wei LH, Li HJ, Guan MC, Wang MD, Pawlik TM, Lau WY, Shen F, Lv GY, Yang T. Sun LY, et al. Hepatobiliary Pancreat Dis Int. 2023 Dec 30:S1499-3872(23)00242-4. doi: 10.1016/j.hbpd.2023.12.004. Online ahead of print. Hepatobiliary Pancreat Dis Int. 2023. PMID: 38199909
Severe pleural effusion after hepatectomy for hepatocellular carcinoma: multicentre retrospective study.
Fan ZQ, Diao YK, Li C, Yao LQ, Zhang CW, Zeng YY, Chen ZX, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Xu X, Liang YJ, Wang XM, Zhang WG, Li J, Wang MD, Wu H, Xu XF, Pawlik TM, Lau WY, Shen F, Yang T, Lv GY. Fan ZQ, et al. BJS Open. 2023 Nov 1;7(6):zrad118. doi: 10.1093/bjsopen/zrad118. BJS Open. 2023. PMID: 38108467 Free PMC article. No abstract available.
107 results